AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Stryker has adjusted its 2025 profit outlook to between 9.5%-10%, up from 8.5%-9.5%, amid strong growth in its medical surgery and neurotechnology unit.

The FDA has approved SetPoint Medical’s neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis.

RFK Jr's statewide tour promoting his Make America Healthy Again (MAHA) agenda has been called “performative” by a US health consultancy.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for CardioTag, Cardiosense’s multimodal, wearable sensor.

Medical device database EUDAMED is viewed by the European Commission as an integral part of the EU MDR and EU IVDR’s implementation.

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.

Precision temperature monitoring and advanced materials are key to ensuring effective outcomes for radiofrequency ablation ...

AdvaMed has praised the CMS' plans to establish a framework to simplify the exchange of healthcare data between patients and providers.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

GE HealthCare and Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.